CD47 and cancer: Notably, disrupting the THBS1-CD47 interaction has been demonstrated to protect normal tissues from the adverse effects of radiotherapy and chemotherapy by fostering protective autophagy and anabolic metabolic repair, simultaneously enhancing the immune destruction of cancer cells64.